View LUK's latest stock price, price target, analyst ratings, earnings information, dividend information, headlines, insider trades and SEC filings in real-time at MarketBeat. Are you considering Leucadia National (NYSE:LUK) stock for your investment portfolio? View LUK's latest stock price, price target, analyst ratings, earnings information, dividend information, headlines, insider trades and SEC filings in real-time at MarketBeat.
Oral Cancer. Tumors of the mouth and throat (oropharyngeal tumors) are common in dogs and include malignant melanoma (the most common canine oral tumor), fibrosarcoma, squamous cell carcinoma and epulides.
Treatment of Canine Lymphoma Lymphoma is the canine tumor most frequently treated with chemotherapy. It is the most common hematopoietic neoplasia of dogs (see Canine Lymphoma) and cats and is also among the most responsive to chemotherapy. Four antineoplastic agents, vincristine, cyclophosphamide, doxorubicin, and prednisone, form the basis for many lymphoma treatment protocols. Treatments based on these four drugs are often abbreviated as CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], OncovinÂ® [a trade name of vincristine], and prednisone) protocols.